Status:
COMPLETED
Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Alzheimer Disease
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to determine if the concomitant administration of either ketoconazole or fluconazole with BMS-708163 will affect the PK of BMS-708163 and to assess safety and tolerability ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy male and postmenopausal female subjects 18-55 yrs old inclusive
- Exclusion:
- Premenopausal women
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00860275
Start Date
April 1 2009
End Date
June 1 2009
Last Update
January 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ppd Development, Lp
Austin, Texas, United States, 78744